Spatial Clusters of Dominant Lineages of Uropathogenic Escherichia coli Revealed

Strategic Insights -

Research published in BMC Infectious Diseases has shed light on the presence of spatial clusters of dominant lineages of uropathogenic Escherichia coli (UPEC) in a community-dwelling patient population. According to the study, 45% of UPEC isolates were identified as pandemic ST lineages, with ST131 being the most prevalent and contributing to the highest number of multidrug-resistant isolates. The study utilized a novel approach to examine geospatial clustering of UTIs caused by common AMR UPEC ST lineages, providing valuable insights for future surveillance efforts to reduce community transmission of AMR UPEC.

Key Takeaways:

  • 45% of uropathogenic Escherichia coli (UPEC) isolates were identified as pandemic ST lineages.
  • ST131 was the most prevalent pandemic ST lineage, comprising 29% of pandemic ST lineages and contributing to the highest number of multidrug-resistant isolates (resistant to 3 classes of antibiotics).
  • Spatial clusters of ST95, ST131, and ST69 were detected in the study, highlighting the potential influence of spatial clusters on the prevalence of AMR UTIs.
  • The study used a novel approach to examine geospatial clustering of UTIs caused by common AMR UPEC ST lineages, providing valuable insights for future surveillance efforts.
  • The findings suggest that the local prevalence of AMR UTIs may be largely influenced by spatial clusters of already-resistant sequence types within a community rather than by the initial selection of resistant strains by antimicrobial agents.

Statistics:

  • 45% of UPEC isolates (N = 247) were identified as pandemic ST lineages.
  • ST131 comprised 72 (29%) of the pandemic ST lineages.
  • 29% of ST131 isolates were highly resistant to 3 classes of antibiotics.
  • ST95, ST131, and ST69 were identified as spatial clusters in the study.

Sources:

  • "Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient population." BMC Infectious Diseases, 2025;25(1):1379.